Furthermore, experiments in animal models suggested that blockade of the A2AR affords neuroprotection, thus raising the possibility that AR antagonists delay the progression of this neurodegenerative disease [74,75,97,98,99,100,101,102,103,104,105,106,107]. This evidence concerns the gene ADORA2A and neurodegenerative disease.